Literature DB >> 1656898

In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine.

G Nesher1, T L Moore, R W Dorner.   

Abstract

The mechanism of action of low dose methotrexate in rheumatoid arthritis has not been established. It has been shown to have an anti-inflammatory effect and to inhibit neutrophil chemotaxis, but the effect on monocytes has not been widely studied. Normal donor peripheral blood monocytes were incubated with methotrexate in vitro and their superoxide production, chemotaxis, and phagocytosis subsequently assessed. Additionally, the influence of different culture media, and of folinic acid, and the methyl donor S-adenosylmethionine, and spermidine on the methotrexate mediated effects were evaluated. It was found that methotrexate in low concentrations inhibited in vitro monocyte chemotaxis and superoxide production but only after prolonged incubation. This inhibition was augmented by incubation in medium containing a low methionine concentration and was abolished by folinic acid and S-adenosylmethionine, suggesting that methotrexate may interfere with specific methylation reactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656898      PMCID: PMC1004509          DOI: 10.1136/ard.50.9.637

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients.

Authors:  J W O'Callaghan; M J Forrest; P M Brooks
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 2.  The cellular pharmacology of methotrexate.

Authors:  I D Goldman; L H Matherly
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

3.  In vitro interactions between endogenous polyamines and superoxide anion.

Authors:  A M Kafy; C G Haigh; D A Lewis
Journal:  Agents Actions       Date:  1986-08

4.  The effects of methotrexate on the production and activity of interleukin-1.

Authors:  R Segal; E Mozes; M Yaron; B Tartakovsky
Journal:  Arthritis Rheum       Date:  1989-04

5.  Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancer.

Authors:  A Goldhirsch; R D Gelber; M N Tattersall; C M Rudenstam; F Cavalli
Journal:  Lancet       Date:  1987-07-18       Impact factor: 79.321

6.  Polyamines stimulate superoxide production in human neutrophils activated by N-fMet-Leu-Phe but not by phorbol myristate acetate.

Authors:  C Guarnieri; A Georgountzos; I Caldarera; F Flamigni; A Ligabue
Journal:  Biochim Biophys Acta       Date:  1987-09-14

7.  Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.

Authors:  N P Hurst; A L Bell; G Nuki
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

8.  Studies on the effect of low dose methotrexate on rat adjuvant arthritis.

Authors:  W L Welles; J Silkworth; A L Oronsky; S S Kerwar; J Galivan
Journal:  J Rheumatol       Date:  1985-10       Impact factor: 4.666

9.  Effects of corticosteroids on human monocyte function.

Authors:  J J Rinehart; S P Balcerzak; A L Sagone; A F LoBuglio
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  The influence of nitrous oxide on methionine, S-adenosylmethionine, and other amino acids.

Authors:  J R Viña; D W Davis; R A Hawkins
Journal:  Anesthesiology       Date:  1986-04       Impact factor: 7.892

View more
  11 in total

1.  Going with the flow: methotrexate, adenosine, and blood flow.

Authors:  B N Cronstein
Journal:  Ann Rheum Dis       Date:  2006-04       Impact factor: 19.103

2.  Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo.

Authors:  Yi-Cheng Wang; En-Pei Isabel Chiang
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 3.  Methotrexate--how does it really work?

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Nat Rev Rheumatol       Date:  2010-03       Impact factor: 20.543

4.  Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate.

Authors:  Ann M Winter-Vann; Barton A Kamen; Martin O Bergo; Stephen G Young; Stepan Melnyk; S Jill James; Patrick J Casey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-15       Impact factor: 11.205

Review 5.  Methotrexate mechanism in treatment of rheumatoid arthritis.

Authors:  Benjamin Friedman; Bruce Cronstein
Journal:  Joint Bone Spine       Date:  2018-08-03       Impact factor: 4.929

Review 6.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

7.  Mécanisme d'action du méthotrexate dans le traitement de la polyarthrite rhumatoïde.

Authors:  Benjamin Friedman; Bruce Cronstein
Journal:  Rev Rhum Ed Fr       Date:  2020-01-11

8.  Methotrexate treatment of FraX fibroblasts results in FMR1 transcription but not in detectable FMR1 protein levels.

Authors:  Cornelia Brendel; Benjamin Mielke; Merle Hillebrand; Jutta Gärtner; Peter Huppke
Journal:  J Neurodev Disord       Date:  2013-09-10       Impact factor: 4.025

Review 9.  The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions.

Authors:  Shahin Shams; Joseph M Martinez; John R D Dawson; Juan Flores; Marina Gabriel; Gustavo Garcia; Amanda Guevara; Kaitlin Murray; Noah Pacifici; Maxemiliano V Vargas; Taylor Voelker; Johannes W Hell; Judith F Ashouri
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

10.  Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer.

Authors:  Christopher G Kanakry; Zhen Li; Yoko Nakai; Yoshitatsu Sei; Daniel R Weinberger
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.